Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKinsey
Express Scripts
Mallinckrodt
Healthtrust
Medtronic

Generated: July 18, 2019

DrugPatentWatch Database Preview

Patent: 7,838,504

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,838,504
Title:Methods and compositions for reducing viral genome amounts in a target cell
Abstract: Methods and compositions for reducing viral genome amounts in a target cell are provided. In the subject methods, the activity of a miRNA is inhibited in a manner sufficient to reduce the amount of viral genome in the target cell, e.g., by introducing a miRNA inhibitory agent in the target cell. Also provided are pharmaceutical compositions, kits and systems for use in practicing the subject methods. The subject invention finds use in a variety of applications, including the treatment of subjects suffering from a viral mediated disease condition, e.g., an HCV mediated disease condition.
Inventor(s): Sarnow; Peter (Palo Alto, CA), Jopling; Catherine L. (Beeston, GB), Lancaster; Alissa M. (Portland, OR)
Assignee: The Board of Trustees of the Leland Standford Junior University (Palo Alto, CA)
Application Number:11/953,705
Patent Claims:see list of patent claims

Details for Patent 7,838,504

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Try a Free Trial The Board of Trustees of the Leland Standford Junior University (Palo Alto, CA) ➤ Try a Free Trial RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Try a Free Trial The Board of Trustees of the Leland Standford Junior University (Palo Alto, CA) ➤ Try a Free Trial RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Try a Free Trial The Board of Trustees of the Leland Standford Junior University (Palo Alto, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,838,504

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2005107816 Feb 23, 2006
World Intellectual Property Organization (WIPO) 2005107816 Nov 17, 2005
United States of America 2005288245 Dec 29, 2005
United States of America 2008234220 Sep 25, 2008
United States of America 2011124707 May 26, 2011
United States of America 2012329856 Dec 27, 2012
United States of America 2015005362 Jan 01, 2015
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Boehringer Ingelheim
Covington
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.